Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors.
about
Energetics of Ortho-7 (oxime drug) translocation through the active-site gorge of tabun conjugated acetylcholinesteraseCompound library development guided by protein structure similarity clustering and natural product structureThe first total synthesis of (±)-cyclophostin and (±)-cyclipostin P: inhibitors of the serine hydrolases acetyl cholinesterase and hormone sensitive lipaseMarine AChE inhibitors isolated from Geodia barretti: natural compounds and their synthetic analogs.Terpenoid alkaloids of the Buxaceae family with potential biological importance.Synthesis and biological evaluation of a phosphonate analog of the natural acetyl cholinesterase inhibitor cyclophostin.Advances in quantitative structure-activity relationship models of anti-Alzheimer's agents.Differential binding of bispyridinium oxime drugs with acetylcholinesterase.Biological activities of ethanolic extracts from deep-sea Antarctic marine sponges.Molecular docking and 3D-QSAR studies of 2-substituted 1-indanone derivatives as acetylcholinesterase inhibitors.3D-QSAR analysis of a new type of acetylcholinesterase inhibitors.Studies on interaction of buffalo brain cystatin with donepezil: an Alzheimer's drugSynthesis, docking and acetylcholinesterase inhibitory assessment of 2-(2-(4-Benzylpiperazin-1-yl)ethyl)isoindoline-1,3-dione derivatives with potential anti-Alzheimer effects.Electronic structure and PCA analysis of covalent and non-covalent acetylcholinesterase inhibitors.Predicting inhibitors of acetylcholinesterase by regression and classification machine learning approaches with combinations of molecular descriptors.Interpretation of the mechanism of acetylcholinesterase inhibition ability by organophosphorus compounds through a new conformational descriptor. an experimental and theoretical study.Acetylcholinesterase Inhibitors: Beneficial Effects on Comorbidities in Patients With Alzheimer's Disease.
P2860
Q28481270-83E43ABE-5522-416E-A9BA-7A073CD3F6F6Q30344285-EB3304A5-86EE-4CC0-8690-E5BBD2332249Q35086284-DB0BDA78-A0A9-4F98-B768-B28D5749BBD8Q35875939-23AED31E-85E0-4435-8716-235F8009A595Q37170780-4996C612-8012-48BB-A54B-CECC9C7DB869Q37303181-849AA96E-EC11-48DB-9113-E549D344BCC0Q38206286-038829C6-A607-481D-B74A-D96CD7CA5606Q39013062-83632A62-287C-4269-9A4F-26446C5E764EQ39172426-BFC9C702-43DE-4461-AF1F-32EE96E7880EQ40151588-D388CA22-FAE8-4E09-8287-70D1DD300F8EQ40167513-A2BC18D3-B2C9-4C73-A83D-DD35841012A5Q42591784-A0DB70FD-4198-4176-A450-E1DE502E3579Q43102241-A4D5795F-523D-4898-9618-BE1D5CACC35BQ43867931-CD726D76-6E63-4239-9861-E1B4B287CACBQ45929007-01140C69-5F6A-4B17-A404-33030BD623D6Q49154084-53EF80E2-EE25-475D-95D7-480BC7C037AFQ49645966-B809E6C5-FA0D-4C7F-93E9-7CC6A74ABF69
P2860
Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors.
@ast
Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors.
@en
type
label
Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors.
@ast
Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors.
@en
prefLabel
Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors.
@ast
Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors.
@en
P356
P1476
Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors.
@en
P304
P356
10.2174/0929867003375254
P577
2000-03-01T00:00:00Z